This post is also available in:
Русский (Russian)
Newmars Group team took a part at the Eurasian Cancer Screening Conference 2018 on May 17-18, 2018 in Minsk, Belarus. The exchange of experience between countries, discussion of problems and solutions, as well as the creation of the unified strategy and the improvement of the already implemented approaches in the development and implementation effective screening programs at the interstate level were the main topic of the conference.
World known experts in cancer screening shared their experience, evidence and expertise among members of the meeting to improve screening implementation. Keynote reports included most challenging problems of this region and issues surrounding screening programs dedicated to breast, cervical, colorectal and prostate cancers.
Within the framework of the exhibition, Newmars Group demonstrated the advanced capabilities of LuViva Cervical Scan, based on the method of computerized spectral fluorescence analysis. Which allows determining the risk of developing cervical cancer in the earliest stages without any use of invasive intervention.
LuViva Cervical Scan aroused deep interest with a positive feedback from physicians of the need for advanced methods in the routine practice of the early oncological diseases detection.
